Full notification file
Member State to which the notification was sent
Date of acknowledgement from the Member State Competent Authority
Title of the Project
Clinical Study: Treatment of Advanced Gastrointestinal Cancer in a Phase I/II trial with modified autologous mesenchymal cells MSC_apceth_101
Proposed period of release:
01/10/2013 to 31/12/2015
Name of the Institute(s) or Company(ies)
apceth GmbH & Co.KG, ;
3. Is the same GMO release planned elsewhere in the Community?
Has the same GMO been notified elsewhere by the same notifier?
GMO is a:
Identity of the GMO:
Genetically modified mesenchymal stem cells (somatic cells) derived from Homo sapiens.
Information relating to the recipient or parental organisms from wich the GMO is derived
Mesenchymal stem cells derived from humans
European Commission administrative information
Consent given by the Member State Competent Authority: